Page 6,650«..1020..6,6496,6506,6516,652..6,6606,670..»

Malaya Business Insight

Posted: Published on July 27th, 2012

Details Published on Friday, 27 July 2012 00:00 STEM cell therapy is being eyed to cure the neck and back pains and other illnesses of former president and now Pampanga Rep. Gloria Arroyo, alternative medicine doctor Antonia Park said yesterday. Arroyo went to Parks Green and Young Health and Wellness Center in Tagaytay City yesterday morning for cleansing and alternative healing. A guard at the La Vista Subdivision in Quezon City, who requested anonymity, said Arroyo left the subdivision at around 7:30 a.m., accompanied by a few staff and a personal nurse. She rode a white Nissan Patrol and her convoy included a gray Toyota Land Cruiser and a police escort. Arroyo was granted bail Wednesday by a Pasay City court after finding that the electoral sabotage case against her was weak. She posted a P1-million cash bond. Stem cell treatment involves the introduction of new adult stem cells into the damaged tissue in order to treat a disease or injury. The ability of new cells to regenerate is seen as having significant potential to replace diseased areas of the body, with minimal risk of rejection and side effects. Park, in a statement distributed to the media, said Arroyo complained … Continue reading

Comments Off on Malaya Business Insight

Global Nanobiotechnology Industry

Posted: Published on July 27th, 2012

NEW YORK, July 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0181059/Global-Nanobiotechnology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechn This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following Technology Segments: Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, & Other Nanomaterials), and Nanodevices/Tools. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 117 companies including many key and niche players worldwide such as Aduro BioTech, Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Agilent Technologies Inc., Asklepios BioPharmaceutical Inc., Biosante Phosphate Pharmaceuticals, Inc., Celgene Corporation, Elan Pharmaceuticals, Elitech Group, Flamel Technologies, Inc., Gilead Sciences Inc., Life Technologies Corporation, NanoBio Corporation, Nanogen, Inc., Nanophase Technologies Corporation, pSivida Ltd., Sigma Aldrich Company, Starpharma Holdings Ltd., Dendritic Nanotechnologies, Inc., SkyePharma Pharmaceuticals, Unidym, Inc., and Zyvex Instruments LLC. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations … Continue reading

Comments Off on Global Nanobiotechnology Industry

Malaya Business Insight

Posted: Published on July 26th, 2012

Details Published on Friday, 27 July 2012 00:00 STEM cell therapy is being eyed to cure the neck and back pains and other illnesses of former president and now Pampanga Rep. Gloria Arroyo, alternative medicine doctor Antonia Park said yesterday. Arroyo went to Parks Green and Young Health and Wellness Center in Tagaytay City yesterday morning for cleansing and alternative healing. A guard at the La Vista Subdivision in Quezon City, who requested anonymity, said Arroyo left the subdivision at around 7:30 a.m., accompanied by a few staff and a personal nurse. She rode a white Nissan Patrol and her convoy included a gray Toyota Land Cruiser and a police escort. Arroyo was granted bail Wednesday by a Pasay City court after finding that the electoral sabotage case against her was weak. She posted a P1-million cash bond. Stem cell treatment involves the introduction of new adult stem cells into the damaged tissue in order to treat a disease or injury. The ability of new cells to regenerate is seen as having significant potential to replace diseased areas of the body, with minimal risk of rejection and side effects. Park, in a statement distributed to the media, said Arroyo complained … Continue reading

Comments Off on Malaya Business Insight

Spectrum Pharmaceuticals Announces Publication Demonstrating Enhanced Survival with ZEVALIN in Premier Medical Journal …

Posted: Published on July 26th, 2012

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today publication of positive long-term clinical data for ZEVALIN (ibritumomab tiuxetan) Injection in patients with advanced, relapsed follicular non-Hodgkins lymphoma (fNHL). The data, published in Blood, the journal of the American Society of Hematology, showed that addition of ZEVALIN following fludarabine, cyclophosphamide, rituximab (FCR) conditioning and nonmyeloablative allogeneic stem cell transplantation (NST) resulted in a significantly improved 6-year overall survival (OS) estimate of 80% (95% CI, 41%-95%) in chemotherapy refractory patients, thereby overcoming a strong negative prognostic factor that typically precludes these patients from receiving other treatment options. As reported in the literature, following three episodes of relapsed disease, patients with chemorefractory disease have a median survival of 1.5 years.1 The clinical trial data were presented most recently at the 53rd American Society of Hematology Annual Meeting in December 2011. It is very encouraging to see the publication of long-term clinical data showing that ZEVALIN's usage in this allogeneic transplantation regimen can contribute to improved overall survival in the abysmal prognostic group of patients with disease progression after multiple chemotherapy regimens and in some … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Spectrum Pharmaceuticals Announces Publication Demonstrating Enhanced Survival with ZEVALIN in Premier Medical Journal …

ACT Issued Broad Patent for Human RPE Cells Derived From All Types of Pluripotent Stem Cells

Posted: Published on July 26th, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has been issued a patent in Australia, patent number 2005325753, Improved modalities for the treatment of degenerative diseases of the retina. The patent broadly covers the use of human retinal pigment epithelial (RPE) cells generated from pluripotent stem cells in the manufacture of pharmaceutical preparations of RPE cells, and the use of those preparations to treat patients with degenerative diseases of the retina such as Age-related Macular Degeneration. The patent covers the pharmaceutical formulation of human RPE cells made from a range of pluripotent stem cells, including both human embryonic stem cells (hESCs) and human induced pluripotent stem (iPS) cells. We continue to make great progress with our patent estate covering RPE therapies, said Gary Rabin, chairman and CEO of ACT. Our ongoing success in securing broad patent protection around the world, including this newly-issued Australian patent, is a testament to our innovative chief scientific officer, Dr. Robert Lanza, and the rest of our scientific team. The efficient production of highly pure RPE cell preparations represents a critical step in the creation of renewable sources of transplantable cells … Continue reading

Comments Off on ACT Issued Broad Patent for Human RPE Cells Derived From All Types of Pluripotent Stem Cells

Arroyo might undergo stem cell therapy

Posted: Published on July 26th, 2012

MANILA, Philippines - Former President Gloria Macapagal-Arroyo might undergo stem cell therapy to improve her health, according to the alternative medicine facility in Tagaytay City that the Pampanga lawmaker visited Thursday. Arroyo came to the facility complaining of difficulty in swallowing because of a bulge in her throat, according to a statement from the Green 8 Young Health & Wellness Center. Her voice has also changed and she is losing weight because she can't swallow solid food. She also has angina, the center said. Arroyo also complained of continuing neck and back pain. "Our center is accepting her for possible stem cell therapy," the alternative medicine facility said. "The stem cell therapy is... strongly considered." It said the Arroyo can undergo such therapy in the Tagaytay center while her physical therapy will continue at the Veterans Memorial Medical Center 4 times a week. The Pampanga lawmaker is seeking treatment at the center through her sister, Cielo Macapagal-Salgado. The center said Salgado was previously diagnosed with a cancerous lump in her breast. "She consulted several doctors and was subsequently subjected to a myrad of treatment procedures. These, however, did not produce the desired results. When she came to our center she … Continue reading

Comments Off on Arroyo might undergo stem cell therapy

Arroyo might undergo stem cell therapy

Posted: Published on July 26th, 2012

MANILA, Philippines - Former President Gloria Macapagal-Arroyo might undergo stem cell therapy to improve her health, according to the alternative medicine facility in Tagaytay City that the Pampanga lawmaker visited Thursday. Arroyo came to the facility complaining of difficulty in swallowing because of a bulge in her throat, according to a statement from the Green 8 Young Health & Wellness Center. Her voice has also changed and she is losing weight because she can't swallow solid food. She also has angina, the center said. Arroyo also complained of continuing neck and back pain. "Our center is accepting her for possible stem cell therapy," the alternative medicine facility said. "The stem cell therapy is... strongly considered." It said the Arroyo can undergo such therapy in the Tagaytay center while her physical therapy will continue at the Veterans Memorial Medical Center 4 times a week. The Pampanga lawmaker is seeking treatment at the center through her sister, Cielo Macapagal-Salgado. The center said Salgado was previously diagnosed with a cancerous lump in her breast. "She consulted several doctors and was subsequently subjected to a myrad of treatment procedures. These, however, did not produce the desired results. When she came to our center she … Continue reading

Posted in Cell Therapy | Comments Off on Arroyo might undergo stem cell therapy

Buy Clomid Without Prescriptions

Posted: Published on July 26th, 2012

JPAGE_CURRENT_OF_TOTAL SAN JUAN (CyberNews) Oficiales de la Agencia Federal para el Manejo de Emergencias (FEMA, por sus siglas en ingls) exhortaron el jueves a los ciudadanos a preparase para los terremotos, realizando varias medidas de seguridad que les ayudarn a prepararse este y otros tipos de desastres. Los recientes terremotos ocurridos en distintas partes del mundo, demuestran la magnitud de la devastacin y destruccin que puede causar un terremoto. Estos eventos son un recordatorio de que es importante estar preparados para todo tipo de riesgos, como los terremotos, que pueden ocurrir en cualquier momento. A diferencia de los huracanes y tornados, los terremotos ocurren sin aviso, y una vez suceden, es muy tarde para preparase. Tomar pasos sencillos, como revisar las recomendaciones de seguridad para terremotos y actualizar su plan de emergencias, puede salvar vidas, dijo Alejandro De La Campa, Director de la Divisin del Caribe de FEMA. Los aos de experiencia han demostrado que pocas veces el movimiento del suelo durante un terremoto es la causa directa de muertes y lesiones. De hecho, la mayora de las lesiones relacionadas a terremotos resultan de paredes colapsadas, cristales y objetos que caen como el resultado del movimiento del suelo o de … Continue reading

Posted in Prescriptions | Comments Off on Buy Clomid Without Prescriptions

Sexual side effects from finasteride can last longer than expected

Posted: Published on July 26th, 2012

How many men would willingly trade in their sex drive for a full head of hair? For some, that might seem like a deal with the devil. Evidence is accumulating, though, that at least a few men make such a Faustian exchange when they accept a prescription for finasteride. This medication is used to reverse male pattern baldness (as Propecia) or control the symptoms of prostate enlargement (as Proscar). A related drug, dutasteride (Avodart), is also used to treat an enlarged prostate. These drugs work by blocking the conversion of the male hormone testosterone to its byproduct dihydrotestosterone (DHT). Research has shown that DHT contributes to both male pattern baldness and prostate gland growth. Blocking DHT production can help men hang on to their hair longer as well as keep their prostates from expanding. The problem is that there are side effects. The most notable are decreased libido, trouble with ejaculation and erectile dysfunction. These are thought to be uncommon, however, and physicians have assumed that they would disappear once the drug was discontinued. The official prescribing information for Propecia is confusing on this matter. On the one hand, doctors are told that sexual side effects resolve when the drug … Continue reading

Posted in Drug Side Effects | Comments Off on Sexual side effects from finasteride can last longer than expected

Oriola-KD Corporation's Interim Report for 1 January – 30 June 2012

Posted: Published on July 26th, 2012

Oriola-KD Corporation Stock Exchange Release 26 July 2012 at 8.30 a.m. Key figures for 1 January - 30 June 2012 Net sales increased by 10.8 per cent to EUR 1,180.6 million (1-6/2011: EUR 1,065.6 million). Operating profit was EUR 9.7 million (1-6/2011: operating loss EUR 29.4 million including an EUR 33.4 million impairment charge related to the Russian Stary Lekar brand and operating profit excluding impairment charge EUR 4.0 million). Net cash flow from operations was EUR -8.1 million (1-6/2011: EUR -16.1 million). Net profit was EUR 3.2 million (1-6/2011: EUR -27.5 million) and earnings per share were EUR 0.02 (1-6/2011: EUR -0.18). Return on equity was 2.2 per cent (1-6/2011: -16.8 per cent). Outlook for 2012 is unchanged: Oriola-KD`s net sales are expected to increase 10-15 per cent and operating profit excluding one-off items is expected to come to EUR 23-33 million in 2012. Key figures for 1 April - 30 June 2012 Net sales increased by 10.1 per cent to EUR 589.7 million (4-6/2011: EUR 535.5 million). Read this article: Oriola-KD Corporation's Interim Report for 1 January - 30 June 2012 … Continue reading

Posted in Wholesale Pharmacy | Comments Off on Oriola-KD Corporation's Interim Report for 1 January – 30 June 2012

Page 6,650«..1020..6,6496,6506,6516,652..6,6606,670..»